Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5626.0000 -53.50 (-0.94%)

NSE Nov 11, 2025 09:58 AM

Near 52W High of ₹5751.00

Volume: 14,886

Alkem Laboratories Ltd.

10 Feb 2024, 12:00AM

5626.00

-0.94%

Alkem Labs (SELL): Good quarter; cut to SELL on stretched valuations

Sell: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Revenue grew 9% YoY in Q3 backed by strong India and ROW growth that offset lower US business

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.